Roundup Weed killer linked to Non-hodgkin's Lymphoma

Through a variety of international studies, Roundup weed killer has been linked to the development of non-Hodgkin’s lymphoma in those who had regular exposure to the product. If you or a loved one developed non-Hodgkin’s lymphoma after using Roundup, contact us to see if you have a legal case.

Do I Have A Case?

Contact Us To Find Out:

Please provide your first and last name:(Required)

What are roundup cancer lawsuits?

Thousands of lawsuits have been filed against Monsanto, and subsequently, Bayer. Plaintiffs claim the use of the glyphosate-based weedkiller caused them to develop non-Hodgkin’s lymphoma. In several high-profile jury trials, jurors awarded millions and in one case, over a billion dollars to plaintiffs. Trial outcomes have been mixed, with some in favor of Bayer. There are currently 30,000 lawsuits pending, including 4,000 cases in a California-based multi-district litigation (MDL).

What is the Roundup settlement and is it too late?

In May 2022, Bayer reached an agreement of close to $11 billion to settle 100 Roundup cancer cases. Bayer acquired Monsanto, the previous manufacturer of Roundup for $63 billion in 2018.


Bayer also announced a Five-Point Plan to “provide a clear path to closure of the U.S. glyphosate litigation.” The plan included setting aside $4.5 billion to “manage anticipated claims, through settlement and litigation” and to replace its “glyphosate-based products in the U.S. residential lawn and garden market with new formulations that rely on alternative active ingredients” by 2023.

What is Glyphosate?

Glyphosate is an herbicide used to control broadleaf plants, weeds, and grasses and is the active ingredient in Roundup weed killer. Roundup is widely used in the United States by home and professional gardeners, agricultural workers, landscapers, and groundskeepers.


Glyphosate is a broad-spectrum systemic herbicide and crop desiccant, which acts by inhibiting an enzyme needed by plants.

Does Glyphosate Cause Cancer?

In March 2015, the International Agency of Research on Cancer (IARC), part of the United Nations’ World Health Organization, issued a report that classified glyphosate, the active ingredient in Monsanto’s Roundup, as a Group 2a carcinogen or a probable cause of cancer.


A broad scientific analysis published in Mutation Research/Reviews in Mutation Research found people with high-level exposure to glyphosate had a 41 percent increased lifetime risk of developing non-Hodgkin’s lymphoma.


Researchers from the University of California Berkeley, the Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Icahn School of Medicine at Mount Sinai, and others collaborated on the report.

What is lymphoma and how is it treated?

Lymphoma is cancer of the lymphatic system, which controls the body’s immune system. The lymphatic system contains lymph nodes, the spleen, the thymus gland, and bone marrow.


According to the Mayo Clinic, the two main types of lymphoma are Hodgkin’s lymphoma and non-Hodgkin’s lymphoma, which is associated with glyphosate.


Treatment for non-Hodgkin’s lymphoma may include chemotherapy, medication, radiation therapy, and in some cases, stem-cell transplant.

What are Signs and Symptoms of Non-Hodgkin’s Lymphoma?

Symptoms of non-Hodgkin’s lymphoma can include:

  • Enlarged lymph nodes (in the neck, armpits, or groin)
  • Persistent fatigue
  • Fever
  • Night sweats
  • Shortness of breath
  • Unexplained weight loss
  • Itchy skin

Contact us and find out easily if you qualify for a Roundup legal claim:

You may reach me at my contact information by autodialed calls, texts and emails. I understand that submitting this information does not create an attorney-client relationship and that the information I submit is not confidential since it may be shared with participating lawyers.